Maisonneuve -Rosemont Installation

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts	COVID-19, Coronaviridae Infections, Digestive System Diseases, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, influenza, intestinal disorder, lung disorder, musculoskeletal system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rheumatic disorder, rheumatoid arthritis, viral infectious disease, viral pneumonia	Recruiting	Phase 2	2026-03-10		NCT06599658

Clinical trials